Zunyan Dai

4.0k total citations
45 papers, 3.0k citations indexed

About

Zunyan Dai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zunyan Dai has authored 45 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Zunyan Dai's work include Epigenetics and DNA Methylation (19 papers), RNA modifications and cancer (12 papers) and Drug Transport and Resistance Mechanisms (7 papers). Zunyan Dai is often cited by papers focused on Epigenetics and DNA Methylation (19 papers), RNA modifications and cancer (12 papers) and Drug Transport and Resistance Mechanisms (7 papers). Zunyan Dai collaborates with scholars based in United States, Germany and China. Zunyan Dai's co-authors include Wolfgang Sadée, Ying Huang, Cátálin Bárbácioru, Christoph Plass, William C. Reinhold, John N. Weinstein, Paul E. Blower, Gregory A. Otterson, Wei‐Guo Zhu and Miguel A. Villalona‐Calero and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Zunyan Dai

43 papers receiving 3.0k citations

Peers

Zunyan Dai

ONCOL

PRM

GENET

Michele D. Vos United States

Laurent Poulain France

José M.A. Moreira Denmark

Masahiro Hitomi United States

Harris G. Yfantis United States

Renza Vento Italy

Zhuchu Chen China

Alexander Pintzas Greece

Tianzuo Zhan Germany

Elena Piskounova United States

Michele D. Vos United States

Zunyan Dai

2.4k ×1.1

472 ×0.5

549 ×0.8

ONCOL

281 ×1.0

PRM

246 ×1.0

GENET

Citations per year, relative to Zunyan Dai Zunyan Dai (= 1×) peers Michele D. Vos

Countries citing papers authored by Zunyan Dai

Since Specialization

Citations

This map shows the geographic impact of Zunyan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zunyan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zunyan Dai more than expected).

Fields of papers citing papers by Zunyan Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zunyan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zunyan Dai. The network helps show where Zunyan Dai may publish in the future.

Co-authorship network of co-authors of Zunyan Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Zunyan Dai. A scholar is included among the top collaborators of Zunyan Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zunyan Dai. Zunyan Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zhen, Y. Ye, Yuxi Zhang, et al.. (2025). Experience of sexual relationship of patients after radical prostatectomy: a qualitative study. Frontiers in Psychology. 16. 1516544–1516544.

Dai, Zunyan, et al.. (2017). Caution in interpretation of disease causality for heterozygous loss-of-function variants in the MYH8 gene associated with autosomal dominant disorder. European Journal of Medical Genetics. 60(6). 312–316. 5 indexed citations

Dai, Zunyan, JoAnn C. Kelly, Aurelia Meloni‐Ehrig, et al.. (2012). Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas. Molecular Cytogenetics. 5(1). 44–44. 26 indexed citations

Ni, Wenjun, Jia Ji, Zunyan Dai, et al.. (2010). Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition. PLoS ONE. 5(11). e13792–e13792. 43 indexed citations

Blower, Paul E., Ji-Hyun Chung, Joseph S. Verducci, et al.. (2008). MicroRNAs modulate the chemosensitivity of tumor cells. Molecular Cancer Therapeutics. 7(1). 1–9. 294 indexed citations

Johnson, Andrew D., Ying Zhang, Audrey C. Papp, et al.. (2008). Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenetics and Genomics. 18(9). 781–791. 83 indexed citations

Blower, Paul E., Joseph S. Verducci, Shili Lin, et al.. (2007). MicroRNA expression profiles for the NCI-60 cancer cell panel. Molecular Cancer Therapeutics. 6(5). 1483–1491. 194 indexed citations

Liu, Ruqing, Paul E. Blower, Jia‐Long Fang, et al.. (2007). Cystine-Glutamate Transporter SLC7A11 Mediates Resistance to Geldanamycin but Not to 17-(Allylamino)-17-demethoxygeldanamycin. Molecular Pharmacology. 72(6). 1637–1646. 30 indexed citations

Dai, Zunyan, Shujun Liu, Guido Marcucci, & Wolfgang Sadée. (2006). 5-Aza-2′-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer). Biochemical and Biophysical Research Communications. 351(2). 455–461. 13 indexed citations

10.

Dai, Zunyan, Cátálin Bárbácioru, Ying Huang, & Wolfgang Sadée. (2006). Prediction of Anticancer Drug Potency from Expression of Genes Involved in Growth Factor Signaling. Pharmaceutical Research. 23(2). 336–349. 19 indexed citations

11.

Cao, Xianhua, Lanyan Fang, Seth Gibbs, et al.. (2006). Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemotherapy and Pharmacology. 59(4). 495–505. 190 indexed citations

12.

Xiao, Jim, Ying Huang, Zunyan Dai, et al.. (2005). Chemoresistance to Depsipeptide FK228 [(E)-(1 S,4 S,10 S,21 R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] Is Mediated by Reversible MDR1 Induction in Human Cancer Cell Lines. Journal of Pharmacology and Experimental Therapeutics. 314(1). 467–475. 59 indexed citations

13.

Huang, Ying, Pascale Anderle, Kimberly J. Bussey, et al.. (2004). Membrane Transporters and Channels. Cancer Research. 64(12). 4294–4301. 231 indexed citations

14.

Dai, Zunyan, Anthony P. Popkie, Wei‐Guo Zhu, et al.. (2004). Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 23(20). 3521–3529. 49 indexed citations

15.

Yu, Li, Chunhui Liu, Kristi L. Bennett, et al.. (2004). A NotI–EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics. 84(4). 647–660. 20 indexed citations

16.

Dai, Zunyan. (2003). A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Human Molecular Genetics. 12(7). 791–801. 127 indexed citations

17.

Zhu, Wei‐Guo, Kanur Srinivasan, Zunyan Dai, et al.. (2003). Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21^Cip1 Promoter. Molecular and Cellular Biology. 23(12). 4056–4065. 217 indexed citations

18.

Dai, Zunyan, Dieter Weichenhan, Yue-Zhong Wu, et al.. (2002). An AscI Boundary Library for the Studies of Genetic and Epigenetic Alterations in CpG Islands. Genome Research. 12(10). 1591–1598. 16 indexed citations

19.

Frühwald, Michael C., M. Sue O’Dorisio, Zunyan Dai, et al.. (2001). Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes Chromosomes and Cancer. 30(1). 38–47. 3 indexed citations

20.

Frühwald, Michael C., M. Sue O’Dorisio, Zunyan Dai, et al.. (2001). Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas–Implications for tumor biology and potential clinical utility. Oncogene. 20(36). 5033–5042. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact